Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VNDA
#3223
Vanda Pharmaceuticals Inc. - Common Stock
5.4
2
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.37%
Monthly Change
+6.27%
6 month change
-31.99%
Year Change
-1.99%
Previous Close
5.4
0
Open
5.4
2
Low
5.4
2
High
5.4
2
Volume
56
Markets
US Stock Market
Healthcare
Biotechnology
VNDA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2006
Quarterly report, Q1 FY2006
2006.05.22
Vanda Pharmaceuticals Inc. quarterly report, Q1 FY2006
10-Q
Current report, 19 Jan 2006
2007.01.19
Vanda Pharmaceuticals Inc. current report, 19 January 2006
8-K
1
...
27
28
29
30
31
32
33
34
News
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates
Vanda Pharmaceuticals - Risks Rising, Rewards Dwindling - Why I'm Downgrading To Hold
Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA)
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates
Wall Street Analysts Predict a 105.03% Upside in Vanda (VNDA): Here's What You Should Know
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates
AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights
Micron and Palantir among market cap stock movers on Tuesday
Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline